Cynthia Hudson

Cynthia Hudson is a prominent figure in the fertility industry, currently serving as a Founding Partner at both NOVA Genomics and Perch Fertility since January 2025. In addition, Cynthia holds positions as President and President-Elect of the New England Fertility Society from February 2024. As a Strategic Advisor for Fertilidad Integral and Sama Fertility since January 2024 and July 2023 respectively, as well as for LEVY Health since October 2022, Cynthia contributes significantly to advancing fertility practices. Cynthia also serves as VP of Clinical Strategy and Executive Director of Embryology Strategy and Operations at TMRW Life Sciences, which pioneers automated fertility cryostorage solutions. Additionally, Cynthia is a Scientific Advisory Board Member at Hamilton Thorne, Inc. and the Founder/CEO of Cellavita LLC, providing management services in the fertility sector. Educational credentials include a Master of Science in Clinical Embryology from the University of Leeds and a Bachelor of Science from Springfield College.